Sartorius Aktiengesellschaft (SRT3.DE)
Makes equipment and chemicals that help scientists grow cells and manufacture medicines.
222.40+0.04%Healthcare
StockGlow Score
Neutral
BearishBullish
1 year ago+22.2%
The outlook
SRT3.DE is trading below both its 50- and 200-day averages, sitting near the midpoint of its 52-week range. Analysts overwhelmingly favor the stock with a Buy consensus, and their average price target sits about 20% above the current level. The high trailing P/E of 78.6 reflects a premium valuation relative to current earnings.
What’s behind the score
Analyst consensusBuy — 1.9 avg of 19 analysts
Price trendBelow its 50- & 200-day averages
52-week range51% of the way from its 52-week low to high
Price targetAvg target +20% vs current price
Analyst price target
~12-month · 19 analysts266.53average target+19.8% vs now
Now 222.40
Low 190.00High 307.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$15.36B
52-wk high
267.70
52-wk low
175.95
50-day avg
231.61
200-day avg
232.70
Trailing P/E
78.6